GIANNI, ALESSANDRO
GIANNI, ALESSANDRO
Dipartimento di Fisiopatologia Medico-Chirurgica e dei Trapianti
[Clinical use of hematopoietic growth factors]
1991 A. M. Gianni, M. Bregni, S. Siena, C. Tarella, M. DiNicola, G. Bonadonna
[Long-term hematopoietic reconstitution after myeloablative antitumor therapy and circulating hematopoietic stem cell transplantation]
1996 S. Siena, M. Bregni, M. Di Nicola, M. Magni, F. Ravagnani, L. Gandola, F. Lombardi, A. M. Gianni
A computational approach to compare microvessel distributions in tumors following antiangiogenic treatments
2009 M. Righi, A. Giacomini, C. Lavazza, D. Sia, C. Carlo-Stella, A. Gianni
A gene controlling fetal hemoglobin expression in adults is not linked to the non-alpha globin cluster
1983 A. Gianni, M. Bregni, M.D. Cappellini, G. Fiorelli, R. Taramelli, B. Giglioni, P. Comi, S. Ottolenghi
A phase 1/2 trial of arginine butyrate and ganciclovir in patients with Epstein-Barr virus-associated lymphoid malignancies
2007 S.P. Perrine, O. Hermine, T. Small, F. Suarez, R. O'Reilly, F. Boulad, J. Fingeroth, M. Askin, A. Levy, S.J. Mentzer, M. Di Nicola, A.M. Gianni, C. Klein, S. Horwitz, D.V. Faller
A standardized flow cytometry protocol for mobilized peripheral CD34+ cells estimation and collection for autotransplantation in cancer patients
1994 B. Brando, S. Siena, M. Bregni, A.M. Gianni, P. Grillo, E. Sommaruga
Absorbed dose and biologically effective dose in patients with high-risk non-Hodgkin’s lymphoma treated with high-activity myeloablative 90Y-ibritumomab tiuxetan (Zevalin®)
2009 C. Chiesa, F. Botta, A. Coliva, M. Maccauro, L. Devizzi, A. Guidetti, C. Carlo-Stella, E. Seregni, A.M. Gianni, E. Bombardieri
ABVD versus BEACOPP for Hodgkin's lymphoma when high-dose salvage is planned
2011 S. Viviani, P.L. Zinzani, A. Rambaldi, E. Brusamolino, A. Levis, V. Bonfante, U. Vitolo, A. Pulsoni, A.M. Liberati, G. Specchia, P. Valagussa, A. Rossi, F. Zaja, E.M. Pogliani, P. Pregno, M. Gotti, A. Gallamini, D. Rota Scalabrini, G. Bonadonna, A. Gianni
Activity of a monoclonal antibody-saporin-6 conjugate against B-lymphoma cells
1988 M. Bregni, D.A. Lappi, S. Siena, A. Formosa, S. Villa, M. Soria, G. Bonadonna, A. Gianni
Adenovirus vectors for gene transduction into mobilized blood CD34+ cells
1998 M. Bregni, S. Shammah, F. Malaffo, M. Di Nicola, M. Milanesi, M. Magni, P. Matteucci, F. Ravagnani, C. T. Jordan, S. Siena, A. M. Gianni
Adjuvant high-dose chemotherapy with autologous hematopoietic stem cell support for high-risk primary breast cancer: results from the Italian national registry
2014 P. Pedrazzoli, G. Martinelli, A.M. Gianni, G.A. Da Prada, A. Ballestrero, G. Rosti, G.L. Frassineti, M. Aieta, S. Secondino, S. Cinieri, R. Fedele, C. Bengala, M. Bregni, D. Grasso, U. De Giorgi, F. Lanza, L. Castagna, B. Bruno, M. Martino
Age- and irradiation-associated loss of bone marrow hematopoietic function in mice is reversed by recombinant human growth hormone (rhGH)
2004 C. Carlo-Stella, M. Di Nicola, R. Milani, P. Longoni, M. Milanesi, C. Bifulco, C. Stucchi, A. Guidetti, L. Cleris, F. Formelli, G. Garotta, A.M. Gianni
Allogeneic stem cell transplantation following reduced-intensity conditioning can induce durable clinical and molecular remissions in relapsed lymphomas : pre-transplant disease status and histotype heavily influence outcome
2007 P. Corradini, A. Dodero, L. Farina, R. Fanin, F. Patriarca, R. Miceli, P. Matteucci, M. Bregni, R. Scimé, F. Narni, E. Pogliani, A. Locasciulli, R. Milani, C. Carniti, A. Bacigalupo, A. Rambaldi, F. Bonifazi, A. Olivieri, A.M. Gianni, C. Tarella
Amantadine potentiates T lymphocyte killing by an anti-pan-T cell (CD5) ricin A-chain immunotoxin
1987 S. Siena, S. Villa, M. Bregni, G. Bonnadonna, A. Gianni
An analysis of which subgroups of multiple myeloma patients, divided according to b(2)-microglobulin and plasma cell labeling index, benefit from high dose vs conventional chemotherapy
1999 M. Boccadoro, C. Tarella, A. Palumbo, C. Argentino, S. Triolo, A. Dominietto, V. Callea, V. M. Lauta, S. Molica, P. Musto, F. Marmont, A. M. Gianni, A. Pileri
An expanded peripheral T cell population to a cytotoxic T lymphocyte (CTL)-defined, melanocyte-specific antigen in metastatic melanoma patients impacts on generation of peptide-specific CTLs but does not overcome tumor escape from immune surveillance in metastatic lesions
1999 A. Anichini, A. Molla, R. Mortarini, G. Tragni, I. Bersani, M. Di Nicola, A. M. Gianni, S. Pilotti, R. Dunbar, V. Cerundolo, G. Parmiani
Analysis of human embryonic hemoglobins and globins by isoelectric focusing
1983 M. Presta, B. Giglioni, S. Ottolenghi, A.M. Gianni, A. Capaldi, M. Trento, G. Saglio
Analysis of plasma cytokines and angiogenic factors in patients with pretreated urothelial cancer receiving Pazopanib : the role of circulating interleukin-8 to enhance the prognostic accuracy
2014 A. Necchi, M. Pennati, N. Zaffaroni, E. Landoni, P. Giannatempo, D. Raggi, L.H. Schwartz, C. Morosi, F. Crippa, E. Farè, N. Nicolai, R. Lanocita, T. Sava, C. Sacco, C. Messina, C. Ortega, F.G. De Braud, R. Salvioni, M.G. Daidone, A.M. Gianni, L. Mariani
Anticancer cell therapy with TRAIL-armed CD34+ progenitor cells
2008 C. Carlo Stella, C. Lavazza, A. Carbone, A.M. Gianni
Antitumor activity of adenovirally transduced CD34+ cells expressing membrane-bound TRAIL
2007 C. Carlo Stella, C. Lavazza, A. Carbone, A.M. Gianni